Apr 2, 2026 12:30PM
Jan 7, 2026 12:00PM
Jan 6, 2026 12:12PM
Jan 6, 2026 12:12PM
Nov 27, 2025 12:00PM
Nov 27, 2025 12:00PM
Sep 22, 2025 04:10PM GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update
May 14, 2025 04:10PM
Apr 29, 2025 03:10PM
Mar 20, 2025 05:10PM
Sep 13, 2023 01:30AM
Apr 13, 2023 04:10PM
Nov 17, 2022 04:10PM
Sep 28, 2022 04:10PM GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
Sep 19, 2022 05:59AM
Sep 19, 2022 01:30AM
Sep 13, 2022 04:10PM
Sep 13, 2022 04:10PM
Dec 17, 2021 05:58AM
Dec 17, 2021 01:00AM
Dec 17, 2021 01:00AM GENFIT: Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership
Nov 2, 2021 05:10PM
Sep 29, 2021 04:10PM
Feb 9, 2021 04:22PM
Feb 9, 2021 04:10PM
Sep 30, 2020 04:05PM
Sep 28, 2020 09:30AM
Sep 24, 2020 04:14PM GENFIT (GNFT) Reports First Patient First Visit for ELATIVE Phase 3 Study Evaluating Elafibranor in PBC
Sep 24, 2020 04:10PM
Jul 22, 2020 04:05PM
May 18, 2020 04:15PM
May 12, 2020 07:38AM
Apr 8, 2020 04:40PM
Mar 31, 2020 02:45AM
Feb 21, 2020 09:12AM Pre-Open Stock Movers 02/21: (BXRX) (CRC) (DBX) Higher (TRUE) (BXC) (EYPT) Lower (more...)
Feb 20, 2020 05:52PM
Feb 20, 2020 05:42PM
Feb 20, 2020 04:08PM
Feb 20, 2020 04:05PM
Nov 26, 2019 05:51AM
Nov 26, 2019 02:46AM
Nov 10, 2019 08:00AM GENFIT Announces Results of NIS4, an Investigational Non-Invasive NASH Diagnostic, at AASLD 2019
Oct 31, 2019 02:45AM
Sep 30, 2019 04:45PM
Sep 26, 2019 04:15PM
Sep 9, 2019 02:03AM
Sep 2, 2019 12:21PM
Jul 29, 2019 02:19AM
Jun 24, 2019 04:12PM GENFIT (GNFT), Terns Pharmaceuticals Announce $228 Million Strategic Partnership to Develop and Commercialize Elafibranor in Greater China
Jun 24, 2019 04:10PM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All